{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:21:06Z","timestamp":1787314866423,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04422-5","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:25:59Z","timestamp":1757766359000},"page":"1423-1437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Revisiting mortality in acromegaly using machine learning"],"prefix":"10.1007","volume":"90","author":[{"given":"Cem","family":"Sulu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonenc","family":"Onay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guldaran","family":"Bakhdiyarli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Numan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande Mefkure","family":"Ozkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necmettin","family":"Tanriover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil","family":"Comunoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Kizilkilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurperi","family":"Gazioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8329-140X","authenticated-orcid":false,"given":"Pinar","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,13]]},"reference":[{"key":"4422_CR1","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1210\/jc.2014-2670","volume":"99","author":"M Mercado","year":"2014","unstructured":"M. Mercado, B. Gonzalez, G. Vargas et al., Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J. Clin. Endocrinol. Metab. 99, 4438\u20134446 (2014). https:\/\/doi.org\/10.1210\/jc.2014-2670.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR2","doi-asserted-by":"publisher","unstructured":"C. Dai, B. Sun, R. Wang et al., The application of artificial intelligence and machine learning in pituitary. Adenomas Front. Oncol. 11(784819) (2021). https:\/\/doi.org\/10.3389\/fonc.2021.784819","DOI":"10.3389\/fonc.2021.784819"},{"key":"4422_CR3","doi-asserted-by":"publisher","unstructured":"C. Sulu, A.B. Bekta\u015f, S. \u015eahin et al., Machine learning as a clinical decision support tool for patients with acromegaly pituitary 25,486\u2013495 (2022) https:\/\/doi.org\/10.1007\/s11102-022-01216-0","DOI":"10.1007\/s11102-022-01216-0"},{"key":"4422_CR4","doi-asserted-by":"publisher","unstructured":"V. Volovici, N.L. Syn, A. Ercole et al., Steps to avoid overuse and misuse of machine learning in clinical research nature medicine 28,1996\u20131999 (2022) https:\/\/doi.org\/10.1038\/s41591-022-01961-6","DOI":"10.1038\/s41591-022-01961-6"},{"key":"4422_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2174\/1389202922666210705124359","volume":"22","author":"H Habehh","year":"2021","unstructured":"H. Habehh, S. Gohel, Machine, Learn. Healthc. Curr. Genomics 22, 291\u2013300 (2021). https:\/\/doi.org\/10.2174\/1389202922666210705124359.","journal-title":"Learn. Healthc. Curr. Genomics"},{"key":"4422_CR6","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"L. Katznelson, E.R. Laws Jr, S. Melmed et al., Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99, 3933\u20133951 (2014). https:\/\/doi.org\/10.1210\/jc.2014-2700.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR7","doi-asserted-by":"publisher","unstructured":"A. Giustina, N. Biermasz, F.F. Casanueva et al., Consensus on criteria for acromegaly diagnosis and remission pituitary 27,7\u201322 (2024) https:\/\/doi.org\/10.1007\/s11102-023-01360-1","DOI":"10.1007\/s11102-023-01360-1"},{"key":"4422_CR8","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1210\/jc.2002-011841","volume":"87","author":"S Melmed","year":"2002","unstructured":"S. Melmed, F.F. Casanueva, F. Cavagnini et al., Guidelines for acromegaly management. J. Clin. Endocrinol. Metab. 87, 4054\u20134058 (2002). https:\/\/doi.org\/10.1210\/jc.2002-011841.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR9","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"M. Fleseriu, I.A. Hashim, N. Karavitaki et al., Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 3888\u20133921 (2016). https:\/\/doi.org\/10.1210\/jc.2016-2118.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR10","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"A Giustina","year":"2010","unstructured":"A. Giustina, P. Chanson, M.D. Bronstein et al., A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95, 3141\u20133148 (2010). https:\/\/doi.org\/10.1210\/jc.2009-2670.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1210\/jcem.85.2.6363","volume":"85","author":"A Giustina","year":"2000","unstructured":"A. Giustina, A. Barkan, F.F. Casanueva et al., Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85, 526\u2013529 (2000). https:\/\/doi.org\/10.1210\/jcem.85.2.6363.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR12","doi-asserted-by":"publisher","unstructured":"E. Knosp, E. Steiner, K. Kitz et al., Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings Neurosurgery 33,610\u2013617; discussion 617\u2013618 (1993) https:\/\/doi.org\/10.1227\/00006123-199310000-00008","DOI":"10.1227\/00006123-199310000-00008"},{"key":"4422_CR13","first-page":"11530","volume":"34","author":"M Le Morvan","year":"2021","unstructured":"M. Le Morvan, J. Josse, E. Scornet et al., What\u2019sa good imputation to predict with missing values?. Adv. Neural. Inf. Process. Syst. 34, 11530\u201311540 (2021).","journal-title":"Adv. Neural. Inf. Process. Syst."},{"key":"4422_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1613\/jair.953","volume":"16","author":"NV Chawla","year":"2002","unstructured":"N.V. Chawla, K.W. Bowyer, L.O. Hall et al., SMOTE: synthetic minority over-sampling technique. J. Artif. Intell. Res. 16, 321\u2013357 (2002).","journal-title":"J. Artif. Intell. Res."},{"key":"4422_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-019-6413-7","volume":"21","author":"D Chicco","year":"2020","unstructured":"D. Chicco, G. Jurman, The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genom. 21, 1\u201313 (2020).","journal-title":"BMC Genom."},{"key":"4422_CR16","doi-asserted-by":"crossref","unstructured":"B.W. Matthews, Comparison of the predicted and observed secondary structure of T4 phage lysozyme biochimica et biophysica acta (BBA)-Protein structure 405,442\u2013451 (1975)","DOI":"10.1016\/0005-2795(75)90109-9"},{"key":"4422_CR17","unstructured":"H. Cram\u00e9r, Mathematical Methods of Statistics (Princeton University Press, 1999)"},{"key":"4422_CR18","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1210\/jcem.84.6.5732","volume":"84","author":"MO Thorner","year":"1999","unstructured":"M.O. Thorner, C.J. Strasburger, Z. Wu et al., Growth hormone (GH) receptor Blockade with a PEG-modified GH (B2036-PEG) lowers serum insulin-like growth factor-I but does not acutely stimulate serum GH. J. Clin. Endocrinol. Metab. 84, 2098\u20132103 (1999). https:\/\/doi.org\/10.1210\/jcem.84.6.5732.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR19","doi-asserted-by":"publisher","unstructured":"X. Antunes, N. Ventura, G.B. Camilo et al., Predictors of surgical outcome and early criteria of remission in acromegaly endocrine 60,415\u2013422 (2018) https:\/\/doi.org\/10.1007\/s12020-018-1590-8","DOI":"10.1007\/s12020-018-1590-8"},{"key":"4422_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.wneu.2015.12.092","volume":"88","author":"O Haliloglu","year":"2016","unstructured":"O. Haliloglu, E. Kuruoglu, H.M. Ozkaya et al., Multidisciplinary approach for acromegaly: A single tertiary center\u2019s. Experience World Neurosurg. 88, 270\u2013276 (2016). https:\/\/doi.org\/10.1016\/j.wneu.2015.12.092.","journal-title":"Experience World Neurosurg."},{"key":"4422_CR21","doi-asserted-by":"publisher","unstructured":"S. Aydin, B. Ozoner, S. Sahin et al., A follow-up study on outcomes of endoscopic transsphenoidal approach for acromegaly. Clin. Neurol. Neurosurg. 198(106201) (2020). https:\/\/doi.org\/10.1016\/j.clineuro.2020.106201","DOI":"10.1016\/j.clineuro.2020.106201"},{"key":"4422_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3171\/jns.1996.85.2.0239","volume":"85","author":"H Long","year":"1996","unstructured":"H. Long, H. Beauregard, M. Somma et al., Surgical outcome after repeated transsphenoidal surgery in acromegaly. J. Neurosurg. 85, 239\u2013247 (1996). https:\/\/doi.org\/10.3171\/jns.1996.85.2.0239.","journal-title":"J. Neurosurg."},{"key":"4422_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1210\/jc.2005-1208","volume":"91","author":"A Colao","year":"2006","unstructured":"A. Colao, R. Attanasio, R. Pivonello et al., Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J. Clin. Endocrinol. Metab. 91, 85\u201392 (2006). https:\/\/doi.org\/10.1210\/jc.2005-1208.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR24","doi-asserted-by":"publisher","unstructured":"A. Goyal-Honavar, S. Sarkar, H.S. Asha et al., Impact of experience on outcomes after endoscopic transsphenoidal surgery for acromegaly world neurosurg 151,e1007-e1015 (2021) https:\/\/doi.org\/10.1016\/j.wneu.2021.05.030","DOI":"10.1016\/j.wneu.2021.05.030"},{"key":"4422_CR25","doi-asserted-by":"publisher","unstructured":"N.J. Gittoes, M.C. Sheppard, A.P. Johnson et al., Outcome of surgery for acromegaly\u2013the experience of a dedicated pituitary surgeon Qjm 92,741\u2013745 (1999) https:\/\/doi.org\/10.1093\/qjmed\/92.12.741","DOI":"10.1093\/qjmed\/92.12.741"},{"key":"4422_CR26","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1210\/jc.2017-00773","volume":"102","author":"G Raverot","year":"2017","unstructured":"G. Raverot, E. Dantony, J. Beauvy et al., Risk of recurrence in pituitary neuroendocrine tumors: A prospective study using a Five-Tiered classification. J. Clin. Endocrinol. Metabolism 102, 3368\u20133374 (2017). https:\/\/doi.org\/10.1210\/jc.2017-00773.","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"4422_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","volume":"122","author":"ASG Micko","year":"2015","unstructured":"A.S.G. Micko, A. W\u00f6hrer, S. Wolfsberger et al., Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J. Neurosurg. JNS 122, 803\u2013811 (2015). https:\/\/doi.org\/10.3171\/2014.12.JNS141083.","journal-title":"J. Neurosurg. JNS"},{"key":"4422_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1530\/eje-10-0255","volume":"163","author":"S Brochier","year":"2010","unstructured":"S. Brochier, F. Galland, M. Kujas et al., Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients European. J. Endocrinol. 163, 193\u2013200 (2010). https:\/\/doi.org\/10.1530\/eje-10-0255.","journal-title":"J. Endocrinol."},{"key":"4422_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.nec.2019.05.005","volume":"30","author":"M Rutkowski","year":"2019","unstructured":"M. Rutkowski, G. Zada, Management of Pituitary Adenomas Invading the Cavernous Sinus Neurosurgery, Clin. North. Am. 30, 445\u2013455 (2019). https:\/\/doi.org\/10.1016\/j.nec.2019.05.005.","journal-title":"Clin. North. Am."},{"key":"4422_CR30","doi-asserted-by":"publisher","unstructured":"E. Lefevre, F. Chasseloup, M. Hage et al., Clinical and therapeutic implications of cavernous sinus invasion in pituitary adenomas endocrine 85,1058\u20131065 (2024) https:\/\/doi.org\/10.1007\/s12020-024-03877-2","DOI":"10.1007\/s12020-024-03877-2"},{"key":"4422_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s40618-016-0567-9","volume":"40","author":"T Apaydin","year":"2017","unstructured":"T. Apaydin, H.M. Ozkaya, F.E. Keskin et al., Daily life reflections of acromegaly guidelines. J. Endocrinol. Invest. 40, 323\u2013330 (2017). https:\/\/doi.org\/10.1007\/s40618-016-0567-9.","journal-title":"J. Endocrinol. Invest."},{"key":"4422_CR32","doi-asserted-by":"publisher","unstructured":"D.S. Lim, M. Fleseriu, The role of combination medical therapy in the treatment of acromegaly pituitary 20,136\u2013148 (2017) https:\/\/doi.org\/10.1007\/s11102-016-0737-y","DOI":"10.1007\/s11102-016-0737-y"},{"key":"4422_CR33","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1055\/a-1274-1276","volume":"129","author":"S Sahin","year":"2021","unstructured":"S. Sahin, M.C. Fidan, O.P. Korkmaz et al., Effectiveness of Cabergoline treatment in patients with acromegaly uncontrolled with ssas: experience of a single tertiary center exp. Clin. Endocrinol. Diabetes 129, 644\u2013650 (2021). https:\/\/doi.org\/10.1055\/a-1274-1276.","journal-title":"Clin. Endocrinol. Diabetes"},{"key":"4422_CR34","doi-asserted-by":"publisher","unstructured":"C.M. Falch, N.C. Olarescu, J. Bollerslev et al., Trends in incidence and mortality risk for acromegaly in norway: a cohort study endocrine 80,152\u2013159 (2023) https:\/\/doi.org\/10.1007\/s12020-022-03275-6","DOI":"10.1007\/s12020-022-03275-6"},{"key":"4422_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/eje-18-0166","volume":"180","author":"MR Postma","year":"2019","unstructured":"M.R. Postma, T.L.C. Wolters, G. van den Berg et al., Postoperative use of somatostatin analogs and mortality in patients with acromegaly. Eur. J. Endocrinol. 180, 1\u20139 (2019). https:\/\/doi.org\/10.1530\/eje-18-0166.","journal-title":"Eur. J. Endocrinol."},{"key":"4422_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1530\/eje-13-0166","volume":"169","author":"F Bogazzi","year":"2013","unstructured":"F. Bogazzi, A. Colao, G. Rossi et al., Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study. Eur. J. Endocrinol. 169, 367\u2013376 (2013). https:\/\/doi.org\/10.1530\/eje-13-0166.","journal-title":"Eur. J. Endocrinol."},{"key":"4422_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/eje-12-0084","volume":"167","author":"M Arosio","year":"2012","unstructured":"M. Arosio, G. Reimondo, E. Malchiodi et al., Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur. J. Endocrinol. 167, 189\u2013198 (2012). https:\/\/doi.org\/10.1530\/eje-12-0084.","journal-title":"Eur. J. Endocrinol."},{"key":"4422_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"A. Colao, D. Ferone, P. Marzullo et al., Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 25, 102\u2013152 (2004). https:\/\/doi.org\/10.1210\/er.2002-0022.","journal-title":"Endocr. Rev."},{"key":"4422_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1210\/jc.2003-031199","volume":"89","author":"IM Holdaway","year":"2004","unstructured":"I.M. Holdaway, R.C. Rajasoorya, G.D. Gamble, Factors influencing mortality in acromegaly. J. Clin. Endocrinol. Metab. 89, 667\u2013674 (2004). 10.1210\/jc.2003\u2013031199.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR40","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1210\/jc.2004-1381","volume":"90","author":"R Kauppinen-M\u00e4kelin","year":"2005","unstructured":"R. Kauppinen-M\u00e4kelin, T. Sane, A. Reunanen et al., A nationwide survey of mortality in acromegaly. J. Clin. Endocrinol. Metab. 90, 4081\u20134086 (2005). 10.1210\/jc.2004\u2009\u2013\u20091381.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1530\/eje-08-0267","volume":"159","author":"IM Holdaway","year":"2008","unstructured":"I.M. Holdaway, M.J. Bolland, Gamble GD A meta-analysis of the effect of Lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur. J. Endocrinol. 159, 89\u201395 (2008). https:\/\/doi.org\/10.1530\/eje-08-0267.","journal-title":"Eur. J. Endocrinol."},{"key":"4422_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/eje-18-0255","volume":"179","author":"F Bolfi","year":"2018","unstructured":"F. Bolfi, A.F. Neves, C.L. Boguszewski et al., Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis. Eur. J. Endocrinol. 179, 59\u201371 (2018). https:\/\/doi.org\/10.1530\/eje-18-0255.","journal-title":"Eur. J. Endocrinol."},{"key":"4422_CR43","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1210\/jc.2003-032041","volume":"89","author":"NR Biermasz","year":"2004","unstructured":"N.R. Biermasz, F.W. Dekker, A.M. Pereira et al., Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. J. Clin. Endocrinol. Metab. 89, 2789\u20132796 (2004). https:\/\/doi.org\/10.1210\/jc.2003-032041.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR44","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1210\/jcem.83.10.5222","volume":"83","author":"B Swearingen","year":"1998","unstructured":"B. Swearingen, F.G. Barker 2nd, L. Katznelson et al., Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J. Clin. Endocrinol. Metab. 83, 3419\u20133426 (1998). https:\/\/doi.org\/10.1210\/jcem.83.10.5222.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR45","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1210\/jc.2013-2450","volume":"99","author":"M Sherlock","year":"2014","unstructured":"M. Sherlock, R.C. Reulen, A. Aragon-Alonso et al., A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone May overestimate risk. J. Clin. Endocrinol. Metab. 99, 478\u2013485 (2014). https:\/\/doi.org\/10.1210\/jc.2013-2450.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR46","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1210\/jcem.83.11.5266","volume":"83","author":"PU Freda","year":"1998","unstructured":"P.U. Freda, K.D. Post, J.S. Powell et al., Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. J. Clin. Endocrinol. Metab. 83, 3808\u20133816 (1998). https:\/\/doi.org\/10.1210\/jcem.83.11.5266.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR47","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1210\/jcem.83.5.4832","volume":"83","author":"SR Peacey","year":"1998","unstructured":"S.R. Peacey, A.A. Toogood, S.M. Shalet, Hypothalamic dysfunction in cured acromegaly is treatment modality dependent. J. Clin. Endocrinol. Metab. 83, 1682\u20131686 (1998). https:\/\/doi.org\/10.1210\/jcem.83.5.4832.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR48","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1210\/jc.2009-1097","volume":"94","author":"M Sherlock","year":"2009","unstructured":"M. Sherlock, R.C. Reulen, A.A. Alonso et al., ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J. Clin. Endocrinol. Metab. 94, 4216\u20134223 (2009). https:\/\/doi.org\/10.1210\/jc.2009-1097.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR49","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1210\/jcem.83.10.5111","volume":"83","author":"A Abosch","year":"1998","unstructured":"A. Abosch, J.B. Tyrrell, K.R. Lamborn et al., Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J. Clin. Endocrinol. Metab. 83, 3411\u20133418 (1998). https:\/\/doi.org\/10.1210\/jcem.83.10.5111.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4422_CR50","doi-asserted-by":"publisher","unstructured":"L. Alexander, D. Appleton, R. Hall et al., Epidemiology of acromegaly in the Newcastle region clin endocrinol (Oxf) 12,71\u201379 (1980) https:\/\/doi.org\/10.1111\/j.1365-2265.1980.tb03135.x","DOI":"10.1111\/j.1365-2265.1980.tb03135.x"},{"key":"4422_CR51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/bf03344942","volume":"16","author":"J Etxabe","year":"1993","unstructured":"J. Etxabe, S. Gaztambide, P. Latorre et al., Acromegaly: an epidemiological study. J. Endocrinol. Invest. 16, 181\u2013187 (1993). https:\/\/doi.org\/10.1007\/bf03344942.","journal-title":"J. Endocrinol. Invest."},{"key":"4422_CR52","doi-asserted-by":"publisher","unstructured":"S. G\u0103loiu, I.D. Toma, D.I. T\u0103nasie et al., High mortality risk among women with acromegaly still persists. Front. Endocrinol. (Lausanne). 15(1348972) (2024). https:\/\/doi.org\/10.3389\/fendo.2024.1348972","DOI":"10.3389\/fendo.2024.1348972"},{"key":"4422_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1530\/eje-16-0117","volume":"175","author":"J Dal","year":"2016","unstructured":"J. Dal, U. Feldt-Rasmussen, M. Andersen et al., Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur. J. Endocrinol. 175, 181\u2013190 (2016). https:\/\/doi.org\/10.1530\/eje-16-0117.","journal-title":"Eur. J. Endocrinol."},{"key":"4422_CR54","doi-asserted-by":"publisher","unstructured":"A. Lavrentaki, A. Paluzzi, J.A. Wass et al., Epidemiology of acromegaly: review of population studies pituitary 20,4\u20139 (2017) https:\/\/doi.org\/10.1007\/s11102-016-0754-x","DOI":"10.1007\/s11102-016-0754-x"},{"key":"4422_CR55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1530\/eje-13-1022","volume":"171","author":"A Colao","year":"2014","unstructured":"A. Colao, S. Vandeva, R. Pivonello et al., Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and campania (Italy). Eur. J. Endocrinol. 171, 263\u2013273 (2014). https:\/\/doi.org\/10.1530\/eje-13-1022.","journal-title":"Eur. J. Endocrinol."},{"key":"4422_CR56","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1530\/erc-16-0106","volume":"23","author":"E Ritvonen","year":"2016","unstructured":"E. Ritvonen, E. L\u00f6yttyniemi, P. Jaatinen et al., Mortality in acromegaly: a 20-year follow-up study. Endocr. Relat. Cancer 23, 469\u2013480 (2016). https:\/\/doi.org\/10.1530\/erc-16-0106.","journal-title":"Endocr. Relat. Cancer"},{"key":"4422_CR57","doi-asserted-by":"publisher","unstructured":"I. Kreitschmann-Andermahr, S. Siegel, B. Kleist et al., Diagnosis and management of acromegaly: the patient\u2019s perspective Pituitary 19,268\u2013276 (2016) https:\/\/doi.org\/10.1007\/s11102-015-0702-1","DOI":"10.1007\/s11102-015-0702-1"},{"key":"4422_CR58","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/erc-17-0253","volume":"24","author":"P Petrossians","year":"2017","unstructured":"P. Petrossians, A.F. Daly, E. Natchev et al., Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge acromegaly survey (LAS). Database Endocr. Relat. Cancer 24, 505\u2013518 (2017). https:\/\/doi.org\/10.1530\/erc-17-0253.","journal-title":"Database Endocr. Relat. Cancer"},{"key":"4422_CR59","doi-asserted-by":"publisher","first-page":"e1815","DOI":"10.1210\/clinem\/dgz317","volume":"105","author":"KH Park","year":"2020","unstructured":"K.H. Park, E.J. Lee, G.H. Seo et al., Risk for acromegaly-related comorbidities by sex in Korean acromegaly. J. Clin. Endocrinol. Metabolism 105, e1815\u2013e1826 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgz317.","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"4422_CR60","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1365-2265.2006.02676.x","volume":"65","author":"UJ Meinhardt","year":"2006","unstructured":"U.J. Meinhardt, K.K.Y. Ho, Modulation of growth hormone action by sex steroids. Clin. Endocrinol. 65, 413\u2013422 (2006). https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02676.x.","journal-title":"Clin. Endocrinol."},{"key":"4422_CR61","doi-asserted-by":"publisher","first-page":"E51","DOI":"10.1210\/jc.2012-2896","volume":"98","author":"A Ciresi","year":"2013","unstructured":"A. Ciresi, M.C. Amato, R. Pivonello et al., The metabolic profile in active acromegaly is Gender-Specific the. J. Clin. Endocrinol. Metabolism 98, E51\u2013E59 (2013). https:\/\/doi.org\/10.1210\/jc.2012-2896.","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"4422_CR62","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1210\/clinem\/dgad141","volume":"108","author":"B Biagetti","year":"2023","unstructured":"B. Biagetti, P. Iglesias, R. Villar-Taibo et al., Mortality in acromegaly diagnosed in older individuals in Spain is higher in women compared to the general Spanish population the. J. Clin. Endocrinol. Metabolism 108, 2193\u20132202 (2023). https:\/\/doi.org\/10.1210\/clinem\/dgad141.","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"4422_CR63","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/ejendo\/lvad106","volume":"189","author":"J Kim","year":"2023","unstructured":"J. Kim, N. Hong, J. Choi et al., Sex differences in mortality in patients with acromegaly: a nationwide cohort study in Korea European. J. Endocrinol. 189, 225\u2013234 (2023). https:\/\/doi.org\/10.1093\/ejendo\/lvad106.","journal-title":"J. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04422-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04422-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04422-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T18:03:12Z","timestamp":1765908192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04422-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,13]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4422"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04422-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,13]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"and Informed Consent\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study was approved by Ethics Committee of Cerrahpasa Faculty of Medicine (approval date 22.05.2023, no: 692023). It is the policy of Pituitary Center to obtain informed consent for the use of anonymous patient data for research purpose at initial admission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The manuscript has been read and approved by all the authors, that the requirements for authorship as stated earlier in this document have been met, and that each author believes that the manuscript represents honest work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}